We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+18.35%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$11.6B
AUM Growth
+$1.31B
Cap. Flow
+$110M
Cap. Flow %
0.94%
Top 10 Hldgs %
19.9%
Holding
462
New
101
Increased
148
Reduced
98
Closed
87

Top Sells

Rank Stock Value
1
CAMT icon
Camtek
CAMT
+$168M
2
CCJ icon
Cameco
CCJ
+$126M
3
ELF icon
e.l.f. Beauty
ELF
+$100M
4
SMCI icon
Super Micro Computer
SMCI
+$96.7M
5
ONTO icon
Onto Innovation
ONTO
+$88.5M

Sector Composition

Rank Sector Weight
1 Healthcare 24.79%
2 Industrials 19.06%
3 Technology 18.73%
4 Consumer Discretionary 12.67%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCS icon
226
Century Communities
CCS
$1.96B
$10.7M 0.09%
+103,762
New +$9.93M
PODD icon
227
Insulet
PODD
$11.8B
$10.6M 0.09%
+45,347
New +$9.31M
TWFG
228
TWFG Inc
TWFG
$356M
$10.4M 0.09%
+385,251
New +$9.99M
XPO icon
229
XPO
XPO
$23.1B
$10.3M 0.09%
+95,434
New +$10.7M
CALX icon
230
Calix
CALX
$2.35B
$10M 0.09%
+258,618
New +$9.5M
BVS icon
231
Bioventus
BVS
$913M
$10M 0.09%
+837,514
New +$7.24M
MKTX icon
232
MarketAxess Holdings
MKTX
$5.71B
$9.95M 0.09%
+38,854
New +$9.11M
GPOR icon
233
Gulfport Energy Corp
GPOR
$2.94B
$9.84M 0.08%
65,029
-118,680
-65% -$17.4M
LGND icon
234
Ligand Pharmaceuticals
LGND
$5.85B
$9.58M 0.08%
+95,738
New +$9.64M
PRAX icon
235
Praxis Precision Medicines
PRAX
$8.52B
$9.55M 0.08%
166,056
-98,632
-37% -$5.33M
OMCL icon
236
Omnicell
OMCL
$1.71B
$9.39M 0.08%
+215,379
New +$8.12M
IONS icon
237
Ionis Pharmaceuticals
IONS
$9.06B
$9.21M 0.08%
+229,969
New +$10.7M
RDFN
238
DELISTED
Redfin
RDFN
$9.12M 0.08%
+727,899
New +$6.69M
BLD
239
DELISTED
TopBuild
BLD
$9.07M 0.08%
+22,296
New +$8.99M
NXE icon
240
NexGen Energy
NXE
$6.33B
$9.05M 0.08%
1,385,441
-1,376,101
-50% -$8.55M
ALNY icon
241
Alnylam Pharmaceuticals
ALNY
$29.5B
$8.9M 0.08%
32,350
-139
-0.4% -$36.2K
EVER icon
242
EverQuote
EVER
$852M
$8.81M 0.08%
417,588
-1,618,773
-79% -$37M
BOW
243
Bowhead Specialty Holdings
BOW
$1.11B
$8.76M 0.08%
312,783
+2,346
+0.8% +$65.8K
LRMR icon
244
Larimar Therapeutics
LRMR
$413M
$8.38M 0.07%
1,279,088
-35,018
-3% -$281K
ACI icon
245
Albertsons Companies
ACI
$5.58B
$8.35M 0.07%
451,942
+108,919
+32% +$2.13M
NBIX icon
246
Neurocrine Biosciences
NBIX
$16.7B
$8.16M 0.07%
70,807
-488
-0.7% -$66.9K
ERII icon
247
Energy Recovery
ERII
$459M
$8.13M 0.07%
+467,227
New +$7.37M
KRNT icon
248
Kornit Digital
KRNT
$734M
$8.09M 0.07%
+313,329
New +$5.77M
SN icon
249
SharkNinja
SN
$22.7B
$7.65M 0.07%
+70,402
New +$6.12M
ORKA
250
Oruka Therapeutics
ORKA
$5.72B
$7.57M 0.07%
+308,795
New +$10.7M

Similar funds

Driehaus Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Driehaus Capital Management held 462 positions worth $11.6B, up 13% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Driehaus Capital Management's Q3 2024 filing shows 101 new, 148 increased, 98 reduced and 87 closed positions. Its largest new stake was Varonis Systems: 1,349,464 shares worth $76.2M. The largest sale was Camtek, an estimated $168M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

  • Driehaus Capital Management's largest Q3 2024 buy was Varonis Systems: 1,349,464 shares worth $76.2M.
  • Driehaus Capital Management added most to Mercado Libre in Q3 2024, an estimated $60.8M increase.
  • Driehaus Capital Management's biggest Q3 2024 reduction was Cameco, cutting an estimated $126M.
  • Driehaus Capital Management fully exited Camtek in Q3 2024, selling an estimated $168M.
  • Driehaus Capital Management's ten largest holdings make up 20% of its $11.6B portfolio in Q3 2024.
  • Driehaus Capital Management opened 101 new positions and closed 87 in Q3 2024.
  • Driehaus Capital Management's portfolio value rose 13% quarter-over-quarter to $11.6B.

Based on Driehaus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.